1
|
Yang L, Hou A, Jiang Q, Cheng M, Liu Y. Methodological Development and Applications of Tryptamine-Ynamide Cyclizations in Synthesizing Core Skeletons of Indole Alkaloids. J Org Chem 2023; 88:11377-11391. [PMID: 37540141 DOI: 10.1021/acs.joc.3c01088] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/05/2023]
Abstract
Over the past two decades, synthetic strategies for synthesizing the skeletons of various indole alkaloids based on tryptamine-ynamide have been continuously developed and applied to the total syntheses or formal total syntheses of related molecules. In this synopsis, we summarized the cyclization pathways of tryptamine-ynamide under different catalytic conditions, emphasizing the reaction mechanism and applications in the syntheses of indole alkaloids.
Collapse
Affiliation(s)
- Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Anbin Hou
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Qing Jiang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| |
Collapse
|
2
|
Sun Z, Zhang X, Fu J, Zhang L, Cheng M, Yang L, Liu Y. Collective Syntheses of 8-Oxoprotoberberines via Sequential In(OTf) 3-Catalyzed Cyclization and Pd(OAc) 2-Catalyzed Heck Coupling. J Org Chem 2023. [PMID: 37172220 DOI: 10.1021/acs.joc.3c00419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
Six 8-oxoprotoberberines were synthesized collectively in four steps with acceptable yields (14-19%), of which the products 8-oxopalmatine, 8-oxopseudopalmatine, 8-oxoberberine, and 8-oxopseudoberberine come from nature. The synthetic route was featured with the In(OTf)3-catalyzed cyclization and Heck coupling. Moreover, the syntheses of the natural products berberine, canadine, and iambertine were achieved via various reductions from 8-oxoberberine, which provided a concise approach to the syntheses of this kind of alkaloids.
Collapse
Affiliation(s)
- Zenghui Sun
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Xinhang Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Jiayue Fu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Lianjie Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| |
Collapse
|
3
|
Zhu J, Li J, Zhang L, Sun S, Wang Z, Li X, Yang L, Cheng M, Lin B, Liu Y. Quantum Mechanical Prediction and Experimental Verification of Au(I)-Catalyzed Substitution-Controlled Syntheses of 1 H-Pyrido[4,3- b]indole and Spiro[indoline-3,3'-pyridine] Derivatives. J Org Chem 2023; 88:5483-5496. [PMID: 37043684 DOI: 10.1021/acs.joc.2c03104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/14/2023]
Abstract
Density functional theory calculations were applied to predict the pathways of gold(I)-catalyzed cycloisomerization of the indole substrates with 1,6-enynes, which were consistent with the ensuing experimental results. The substitution-controlled synthesis led to the formation of 1H-pyrido[4,3-b]indole and spiro[indoline-3,3'-pyridine] derivatives in a tunable way. The reactions had good functional group tolerances, and a possible mechanism was proposed based on the computational and experimental results.
Collapse
Affiliation(s)
- Jiang Zhu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Jiaji Li
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Lianjie Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Shitao Sun
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Zhaobo Wang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Xiang Li
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| |
Collapse
|
4
|
Sun S, Hao J, Cheng M, Liu Y, Lin B. Computational insight into gold(I)-catalyzed intramolecular regioselectivity of tryptamine-ynamide cycloisomerizations. Org Biomol Chem 2023; 21:2610-2619. [PMID: 36896738 DOI: 10.1039/d3ob00079f] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/05/2023]
Abstract
The regioselectivity for gold(I)-catalyzed intramolecular cycloisomerizations of tryptamine-ynamides has long been elusive despite various synthetic examples of similar substrates being available. Computational studies were carried out to provide insight into the mechanisms and the origin of the substrate-dependent regioselectivity of these transformations. Based on the analyses of non-covalent interactions, distortion/interaction, and energy decomposition on the interactions between the terminal substituent of alkynes and the gold(I) catalytic ligand, the electrostatic effect was determined to be the key factor for α-position selectivity while the dispersion effect was determined to be the key factor for β-position selectivity. Our computational results were consistent with the experimental observations. This study provides useful guidance for understanding other similar gold(I)-catalyzed asymmetric alkyne cyclization reactions.
Collapse
Affiliation(s)
- Shitao Sun
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
| | - Jinle Hao
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
| |
Collapse
|
5
|
Zhu BH, Ye SB, Nie ML, Xie ZY, Wang YB, Qian PC, Sun Q, Ye LW, Li L. I 2 -Catalyzed Cycloisomerization of Ynamides: Chemoselective and Divergent Access to Indole Derivatives. Angew Chem Int Ed Engl 2023; 62:e202215616. [PMID: 36573021 DOI: 10.1002/anie.202215616] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2022] [Indexed: 12/28/2022]
Abstract
Herein, an I2 -catalyzed unprecedented cycloisomerization of ynamides is developed, furnishing various functionalized bis(indole) derivatives in generally good to excellent yields with wide substrate scope and excellent atom-economy. This protocol not only represents the first molecular-iodine-catalyzed tandem complex alkyne cycloisomerizations, but also constitutes the first chemoselective cycloisomerization of tryptamine-ynamides involving distinctively different C(sp3 )-C(sp3 ) bond cleavage and rearrangement. Moreover, chiral tetrahydropyridine frameworks containing two stereocenters are obtained with moderate to excellent diastereoselectivities and excellent enantioselectivities. Meanwhile, cycloisomerization and aromatization of ynamides produce pyrrolyl indoles with high efficiency enabled by I2 . Additionally, control experiments and theoretical calculations reveal that this reaction probably undergoes a tandem 5-exo-dig cyclization/rearrangement process.
Collapse
Affiliation(s)
- Bo-Han Zhu
- College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou, 325035, China.,Wenzhou Key Laboratory of Technology and Application of Environmental Functional Materials, Institute of New Materials & Industry Technology, Wenzhou University, Wenzhou, 325000, China
| | - Sheng-Bing Ye
- College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou, 325035, China.,Wenzhou Key Laboratory of Technology and Application of Environmental Functional Materials, Institute of New Materials & Industry Technology, Wenzhou University, Wenzhou, 325000, China
| | - Min-Ling Nie
- College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou, 325035, China.,Wenzhou Key Laboratory of Technology and Application of Environmental Functional Materials, Institute of New Materials & Industry Technology, Wenzhou University, Wenzhou, 325000, China
| | - Zhong-Yang Xie
- College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou, 325035, China.,Wenzhou Key Laboratory of Technology and Application of Environmental Functional Materials, Institute of New Materials & Industry Technology, Wenzhou University, Wenzhou, 325000, China
| | - Yi-Bo Wang
- College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou, 325035, China.,Wenzhou Key Laboratory of Technology and Application of Environmental Functional Materials, Institute of New Materials & Industry Technology, Wenzhou University, Wenzhou, 325000, China
| | - Peng-Cheng Qian
- College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou, 325035, China.,Wenzhou Key Laboratory of Technology and Application of Environmental Functional Materials, Institute of New Materials & Industry Technology, Wenzhou University, Wenzhou, 325000, China
| | - Qing Sun
- Key Laboratory of Jiangxi Province for Persistent Pollutants Control and Resources Recycle, Nanchang Hangkong University, Nanchang, 330063, China
| | - Long-Wu Ye
- State Key Laboratory of Physical Chemistry of Solid Surfaces and College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, China
| | - Long Li
- College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou, 325035, China.,Wenzhou Key Laboratory of Technology and Application of Environmental Functional Materials, Institute of New Materials & Industry Technology, Wenzhou University, Wenzhou, 325000, China.,State Key Laboratory of Physical Chemistry of Solid Surfaces and College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, China
| |
Collapse
|
6
|
Musabirov IZ, Gataullin RR. New Synthetic Approaches to Benzo-Fused Spiro Heterocycles. RUSSIAN JOURNAL OF ORGANIC CHEMISTRY 2022. [DOI: 10.1134/s1070428022100013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
7
|
Yamaoka Y, Yamasaki D, Kajiwara D, Shinozaki M, Yamada KI, Takasu K. Lewis Acid-Catalyzed Diastereoselective Domino Reaction of Ene-Ynamide with Trimethylsilyl Cyanide to Construct Spiroindolines. Org Lett 2022; 24:4389-4393. [PMID: 35687516 DOI: 10.1021/acs.orglett.2c01607] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The Zn(OTf)2-catalyzed domino reaction of enamide-ynamides in the presence of trimethylsilyl cyanide as an external nucleophile to construct spirocyclic indolines was developed. This domino reaction involved cyclization of enamide to ynamide to generate 4',5'-dihydrospiro[indoline-3,3'-pyrrol]-1'-ium followed by cyanide addition to produce spiroindolopyrrolidines with good diastereoselectivity.
Collapse
Affiliation(s)
- Yousuke Yamaoka
- Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
| | - Daisuke Yamasaki
- Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
| | - Daigo Kajiwara
- Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
| | - Makiko Shinozaki
- Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
| | - Ken-Ichi Yamada
- Graduate School of Pharmaceutical Sciences, Tokushima University, Shomachi, Tokushima 770-8505, Japan
| | - Kiyosei Takasu
- Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
| |
Collapse
|
8
|
Benaglia M, Greco SJ, Westphal R, Venturini Filho E, Medici F. Stereoselective Domino Reactions in the Synthesis of Spiro Compounds. SYNTHESIS-STUTTGART 2022. [DOI: 10.1055/a-1771-0641] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
AbstractThis review summarizes the latest developments in asymmetric domino reactions, with the emphasis on the preparation of spiro compounds. Discussions on the stereoselectivity of the transformations, the reaction mechanisms, the rationalization of the stereochemical outcome, and the applications of domino reactions to the synthesis of biologically active molecules and natural products are included when appropriate.1 Introduction2 Asymmetric Domino Reactions2.1 Domino Reactions Initiated by Michael Reactions2.2 Domino Reactions Initiated by Mannich Reactions2.3 Domino Reactions Initiated by Knoevenagel Reactions2.4 Domino Reactions Initiated by Cycloaddition Reactions2.5 Domino Reactions Initiated by Metal Insertion2.6 Other Mechanisms3 Conclusion
Collapse
|
9
|
Chen Y, Wang Z, Zhao W, Sun S, Yang L, Zhang J, Zhang D, Cheng M, Lin B, Liu Y. Ag(I)/PPh 3-catalyzed diastereoselective syntheses of spiro[indole-3,4'-piperidine] derivatives via cycloisomerizations of tryptamine-ynamides. Chem Commun (Camb) 2022; 58:3051-3054. [PMID: 35165679 DOI: 10.1039/d1cc07298f] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
A Ag(I)/PPh3-catalyzed chelation-controlled cycloisomerization of tryptamine-ynamide was developed to access the spiro[indole-3,4'-piperidine] scaffold in a racemic and diastereoselective manner. The diastereoselective products were achieved by a chiron approach. Density functional theory (DFT) calculations indicated that strong non-covalent effects between the substrate and catalyst/ligand complex stabilized the spiroindoleninium intermediate via cation-π-π interactions.
Collapse
Affiliation(s)
- Yanyu Chen
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Zhaobo Wang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Wutong Zhao
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.
| | - Shitao Sun
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Junpeng Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Di Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. .,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| |
Collapse
|
10
|
Lin X, Zhao C, Wang D, Wu G, Chen G, Chen S, Ren H, Deng D, Xu Y, Hu X, Liu Y. BiCl
3
‐Mediated Tandem Cyclization of Tryptamine‐Derived Ynamide: Concise Synthesis of Pentacyclic Spiroindolines and Tricyclic Indole Derivatives. Adv Synth Catal 2021. [DOI: 10.1002/adsc.202101232] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- Xiao‐Tong Lin
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Cheng Zhao
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Da‐Ru Wang
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Guang‐Cheng Wu
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Guo‐Shu Chen
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Shu‐Jie Chen
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Hai Ren
- State Key Laboratory of Functions and Applications of Medicinal Plants Guizhou Medical University Guiyang 550014 People's Republic of China
| | - Dong‐Sheng Deng
- College of Chemistry and Chemical Engineering Luoyang Normal University Luoyang 471934 People's Republic of China
| | - Yi‐Bing Xu
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Xiao‐Wei Hu
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
| | - Yun‐Lin Liu
- School of Chemistry and Chemical Engineering Guangzhou University 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center Guangzhou 510006 People's Republic of China
- State Key Laboratory of Functions and Applications of Medicinal Plants Guizhou Medical University Guiyang 550014 People's Republic of China
- Guangdong Provincial Key Laboratory of Catalysis Southern University of Science and Technology Shenzhen 518055 People's Republic of China
| |
Collapse
|
11
|
Yang L, Huang S, Huang R, Hou A, Zhang S, Su H, Ding X, Lin B, Cheng M, Liu Y. Total Syntheses of Aspidospermidine, N-Methylaspidospermidine, N-Acetylaspidospermidine, and Aspidospermine via a Tandem Cyclization of Tryptamine-Ynamide. Org Lett 2021; 23:6471-6476. [PMID: 34339196 DOI: 10.1021/acs.orglett.1c02287] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
The total syntheses of aspidospermidine, N-methylaspidospermidine, N-acetylaspidospermidine, and aspidospermine were achieved from a common pentacyclic indoline intermediate. The common pentacyclic indoline intermediate was synthesized on a gram scale through a Stork-enamine alkylation of 1H-pyrrolo[2,3-d]carbazole derivatives, which were prepared through a Brønsted acid-catalyzed tandem cyclization of tryptamine-ynamide. The scalable synthesis of 1H-pyrrolo[2,3-d]carbazole afforded facile access and a practical approach to the Aspidosperma indole alkaloid family.
Collapse
Affiliation(s)
- Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Siwen Huang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Rongkang Huang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Anbin Hou
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Sen Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Hongwei Su
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Xiaohong Ding
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.,Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| |
Collapse
|
12
|
Luna A, Herrera F, Higuera S, Murillo A, Fernández I, Almendros P. AgNO3·SiO2: Convenient AgNPs source for the sustainable hydrofunctionalization of allenyl-indoles using heterogeneous catalysis. J Catal 2020. [DOI: 10.1016/j.jcat.2020.06.002] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
13
|
Stevens H, Duan PC, Dechert S, Meyer F. Competing H 2 versus Intramolecular C-H Activation at a Dinuclear Nickel Complex via Metal-Metal Cooperative Oxidative Addition. J Am Chem Soc 2020; 142:6717-6728. [PMID: 32163715 DOI: 10.1021/jacs.0c00758] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Nickel(I) metalloradicals bear great potential for the reductive activation of challenging substrates but are often too unstable to be isolated. Similar chemistry may be enabled by nickel(II) hydrides that store the reducing equivalents in hydride bonds and reductively eliminate H2 upon substrate binding. Here we present a pyrazolate-based bis(β-diketiminato) ligand [LPh]3- with bulky m-terphenyl substituents that can host two Ni-H units in close proximity. Complexes [LPh(NiII-H)2]- (3) are prone to intramolecular reductive H2 elimination, and an equilibrium between 3 and orthometalated dinickel(II) monohydride complexes 2 is evidenced. 2 is shown to form via intramolecular metal-metal cooperative phenyl group C(sp2)-H oxidative addition to the dinickel(I) intermediate [LPhNiI2]- (4). While NiI species have been implicated in catalytic C-H functionalization, discrete activation of C-H bonds at NiI complexes has rarely been described. The reversible H2 and C-H reductive elimination/oxidative addition equilibrium smoothly unmasks the powerful 2-electron reductant 4 from either 2 or 3, which is demonstrated by reaction with benzaldehyde. A dramatic cation effect is observed for the rate of interconversion of 2 and 3 and also for subsequent thermally driven formation of a twice orthometalated dinickel(II) complex 6. X-ray crystallographic and NMR titration studies indicate distinct interaction of the Lewis acidic cation with 2 and 3. The present system allows for the unmasking of a highly reactive [LPhNiI2]- intermediate 4 either via elimination of H2 from dihydride 3 or via reductive C-H elimination from monohydride 2. The latter does not release any H2 byproduct and adds a distinct platform for metal-metal cooperative two-electron substrate reductions while circumventing the isolation of any unstable superreduced form of the bimetallic scaffold.
Collapse
Affiliation(s)
- Hendrik Stevens
- Universität Göttingen, Institut für Anorganische Chemie, Tammannstrasse 4, D-37077 Göttingen, Germany
| | - Peng-Cheng Duan
- Universität Göttingen, Institut für Anorganische Chemie, Tammannstrasse 4, D-37077 Göttingen, Germany
| | - Sebastian Dechert
- Universität Göttingen, Institut für Anorganische Chemie, Tammannstrasse 4, D-37077 Göttingen, Germany
| | - Franc Meyer
- Universität Göttingen, Institut für Anorganische Chemie, Tammannstrasse 4, D-37077 Göttingen, Germany
| |
Collapse
|
14
|
Liang G, Pang Y, Ji Y, Zhuang K, Li L, Xie F, Yang L, Cheng M, Lin B, Liu Y. Diastereoselective Syntheses of Spiro[indoline-3,4′-pyridin]-2-yl Carbamates via AgOTf/Ph3P-Catalyzed Tandem Cyclizations of Tryptamine-Ynesulfonamides. J Org Chem 2020; 85:3010-3019. [DOI: 10.1021/acs.joc.9b02839] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Guoduan Liang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yadong Pang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yanjun Ji
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Kaitong Zhuang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Linji Li
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Fukai Xie
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P. R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P. R. China
| |
Collapse
|
15
|
Liang G, Ji Y, Liu H, Pang Y, Zhou B, Cheng M, Liu Y, Lin B, Liu Y. Silver Triflate/
N
‐Fluorobenzenesulfonimide‐Catalyzed Cycloisomerization of Tryptamine‐Ynamide to Spiro[indoline‐3,4′‐piperidine] Induced by Cation‐π‐π Interactions between Substrate and Metal Ligand. Adv Synth Catal 2019. [DOI: 10.1002/adsc.201901175] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Affiliation(s)
- Guoduan Liang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Wuya College of InnovationShenyang Pharmaceutical University Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| | - Yanjun Ji
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| | - Hairui Liu
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Wuya College of InnovationShenyang Pharmaceutical University Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| | - Yadong Pang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Wuya College of InnovationShenyang Pharmaceutical University Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| | - Bojun Zhou
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Wuya College of InnovationShenyang Pharmaceutical University Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| | - Yang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)Ministry of Education Shenyang 110016 People's Republic of China
- Wuya College of InnovationShenyang Pharmaceutical University Shenyang 110016 People's Republic of China
- Institute of Drug Research inMedicine Capital of China Benxi 117000 People's Republic of China
| |
Collapse
|
16
|
Pang Y, Liang G, Xie F, Hu H, Du C, Zhang X, Cheng M, Lin B, Liu Y. N-Fluorobenzenesulfonimide as a highly effective Ag(i)-catalyst attenuator for tryptamine-derived ynesulfonamide cycloisomerization. Org Biomol Chem 2019; 17:2247-2257. [DOI: 10.1039/c9ob00059c] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
N-Fluorobenzenesulfonimide was identified for the first time as a unique Ag(i)-catalyst attenuator in the annulation of a tryptamine-derived ynesulfonamide to an azepino[4,5-b]indole.
Collapse
Affiliation(s)
- Yadong Pang
- Key Laboratory of Structure-Based Drug Design and Discovery Shenyang Pharmaceutical University
- Ministry of Education
- Shenyang 110016
- P. R. China
- Institute of Drug Research in Medicine Capital of China
| | - Guoduan Liang
- Key Laboratory of Structure-Based Drug Design and Discovery Shenyang Pharmaceutical University
- Ministry of Education
- Shenyang 110016
- P. R. China
- Institute of Drug Research in Medicine Capital of China
| | - Fukai Xie
- Key Laboratory of Structure-Based Drug Design and Discovery Shenyang Pharmaceutical University
- Ministry of Education
- Shenyang 110016
- P. R. China
- Institute of Drug Research in Medicine Capital of China
| | - Haibin Hu
- Key Laboratory of Structure-Based Drug Design and Discovery Shenyang Pharmaceutical University
- Ministry of Education
- Shenyang 110016
- P. R. China
- Institute of Drug Research in Medicine Capital of China
| | - Chuan Du
- Key Laboratory of Structure-Based Drug Design and Discovery Shenyang Pharmaceutical University
- Ministry of Education
- Shenyang 110016
- P. R. China
- Institute of Drug Research in Medicine Capital of China
| | - Xinhang Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery Shenyang Pharmaceutical University
- Ministry of Education
- Shenyang 110016
- P. R. China
- Institute of Drug Research in Medicine Capital of China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery Shenyang Pharmaceutical University
- Ministry of Education
- Shenyang 110016
- P. R. China
- Institute of Drug Research in Medicine Capital of China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery Shenyang Pharmaceutical University
- Ministry of Education
- Shenyang 110016
- P. R. China
- Institute of Drug Research in Medicine Capital of China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery Shenyang Pharmaceutical University
- Ministry of Education
- Shenyang 110016
- P. R. China
- Institute of Drug Research in Medicine Capital of China
| |
Collapse
|
17
|
Liu C, Sun Z, Xie F, Liang G, Yang L, Li Y, Cheng M, Lin B, Liu Y. Gold(i)-catalyzed pathway-switchable tandem cycloisomerizations to indolizino[8,7-b]indole and indolo[2,3-a]quinolizine derivatives. Chem Commun (Camb) 2019; 55:14418-14421. [DOI: 10.1039/c9cc05667j] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
A common strategy was developed to access both indolizino[8,7-b]indole and indolo[2,3-a]quinolizine derivatives from tryptamine-N-ethynylpropiolamide substrates in a switchable fashion via tuning both the electronic effects and steric effects.
Collapse
Affiliation(s)
- Chengjun Liu
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Wuya College of Innovation
| | - Zenghui Sun
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Wuya College of Innovation
| | - Fukai Xie
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Wuya College of Innovation
| | - Guoduan Liang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Wuya College of Innovation
| | - Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Institute of Drug Research in Medicine Capital of China
| | - Yaqiao Li
- College of Chemistry
- Jilin University
- Changchun
- P. R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Institute of Drug Research in Medicine Capital of China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Institute of Drug Research in Medicine Capital of China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
- Ministry of Education
- Shenyang 110016
- P. R. China
- Wuya College of Innovation
| |
Collapse
|